Update on Huntington's disease: advances in care and emerging therapeutic options.
about
CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseasesMetabolic profiling for the identification of Huntington biomarkers by on-line solid-phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis tools.Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing.Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice.Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse ModelA randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An In vitro ModelFifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate.Pridopidine for the treatment of Huntington's disease.Huntington's disease: Molecular basis of pathology and status of current therapeutic approachesProspective Evaluation of Predictive DNA Testing for Huntington's Disease in a Large German Center.Investigational agents for the management of Huntington's disease.Discrepancy in prevalence of Huntington's disease in two Swedish regions.Huntington's disease is a multi-system disorder.Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic TestingA shared mechanism of muscle wasting in cancer and Huntington's disease.Changes in cardiac nucleotide metabolism in Huntington's disease.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.Neuro-Cardio Mechanisms in Huntington's Disease and Other Neurodegenerative Disorders.Factors contributing to clinical picture and progression of Huntington's disease
P2860
Q26799640-F9A50164-C602-4CC2-96D9-46DC9682EB43Q31032933-782E15D7-652E-4E10-98B4-6154F136A488Q33752590-BD6262AF-1C11-4A6A-B44F-E65043FC6D71Q36291565-C201BD41-28B3-4FD0-A245-8A04458385DDQ37237181-7A47D643-A999-4266-AAFB-AC5C6AA31623Q37675437-214A4550-448F-49E0-BE7A-380640D5D236Q38383918-9B8B29D0-7B6F-458C-AFD2-9966CF989A08Q38563981-0DE2DD47-F064-4D3C-96CD-369ACA2D46ADQ38680458-37650CD0-8812-42FE-96EA-588988FB16B3Q38697132-7AB7BBCF-6B3F-4DD7-84AC-C4EE427F4E6DQ38735562-BD717175-B5D1-4511-83BE-F5F074DA706FQ38815118-5338A899-3E3F-4B6E-9BFA-CBA857A9CB18Q38865495-EA079057-FB24-4AC1-B28C-2762A64033B8Q39031769-C441E08B-C914-4D0F-83EB-09F5CCD55109Q40251001-AF5719C2-2683-4539-B610-917B8F29D369Q41597422-AB46C084-E1F8-4D3D-A7E6-334669DFB40EQ42288611-FCFCE249-25F1-4808-A45F-EE92E55FB9E8Q43131306-C7997956-893D-4715-968C-BE1906AD146FQ45299252-5EF04645-B9BE-4C30-98B4-FE981BCBC1C4Q52721984-AF25A63E-AA9E-4D03-90ED-388B7B2F9C9EQ54979284-CD3391CE-D1B3-4468-B0EB-DCEF6FE27921Q58805411-7A3A059C-6DE8-4AD0-BB32-A4C7B9B618BE
P2860
Update on Huntington's disease: advances in care and emerging therapeutic options.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Update on Huntington's disease: advances in care and emerging therapeutic options.
@ast
Update on Huntington's disease: advances in care and emerging therapeutic options.
@en
type
label
Update on Huntington's disease: advances in care and emerging therapeutic options.
@ast
Update on Huntington's disease: advances in care and emerging therapeutic options.
@en
prefLabel
Update on Huntington's disease: advances in care and emerging therapeutic options.
@ast
Update on Huntington's disease: advances in care and emerging therapeutic options.
@en
P50
P1476
Update on Huntington's disease: advances in care and emerging therapeutic options.
@en
P2093
G Bernhard Landwehrmeyer
P304
P356
10.1016/J.PARKRELDIS.2014.12.013
P577
2014-12-19T00:00:00Z